Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT01786603 · COMPLETED
Trial details
- NCT number
- NCT01786603
- Sponsor
- Richard Barohn, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-21
- Primary completion
- 2016-07-27
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.